# Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)

> **NCT00882024** · PHASE2 · COMPLETED · sponsor: **Nuon Therapeutics, Inc.** · enrollment: 250 (estimated)

## Conditions studied

- Active Rheumatoid Arthritis

## Interventions

- **DRUG:** Tranilast
- **DRUG:** Tranilast
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00882024
- **Lead sponsor:** Nuon Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2011-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00882024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00882024, "Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00882024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*